Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
Experimental Study Shows that Learned Immunosuppressive Placebo Responses Attenuate Disease Progression in a Rat Model of Arthritis
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
FDA Authorizes an Emergency Use for Bamlanivimab – an Investigational Monoclonal Antibody – for the Treatment of Mild to Moderate COVID-19November 11, 2020
NIH begins the first large randomized controlled trial of the combination of interferon beta-1a and remdesivir for treating COVID-19August 13, 2020
First Evidence that the Antiviral Remdesivir Shows Efficacy in an Animal Model (Rhesus Macaques) of COVID-19April 24, 2020
β2-Adrenoceptor-Mediated Upregulation of IL-17 May Contribute to Pulmonary Immunopathology in COVID-19: Does Blockade of IL-17 and β-Adrenergic Effects Hold a Therapeutic Potential?April 9, 2020
High Affinity Human Antibody Component Identified as a Potential Targeted SARS-Cov-2 TherapyNovember 3, 2020
The European Commission Approves Remdesivir for the Treatment of Severe Cases of COVID-19July 4, 2020
